Vital signs

PetPace™ Launches PetPace 2.0, the Only Vet-Grade AI-Powered Canine Pet Collar Providing Continuous Life-Saving Medical Insights for Vets, Researchers and Pet Owners

Retrieved on: 
Monday, March 4, 2024

PetPace ™, a leader in advanced pet health monitoring, announced today the launch of PetPace 2.0, an AI-powered, life-saving smart dog collar delivering continuous, near real-time medical insights for early detection, treatment, monitoring, and GPS tracking for canine health.

Key Points: 
  • PetPace ™, a leader in advanced pet health monitoring, announced today the launch of PetPace 2.0, an AI-powered, life-saving smart dog collar delivering continuous, near real-time medical insights for early detection, treatment, monitoring, and GPS tracking for canine health.
  • PetPace improves the health and quality of life of pets through remote monitoring, to bring peace of mind to pet owners.
  • Only PetPace AI-powered smart dog collar provides immediate health alerts, continuous vital sign monitoring, proprietary wellness scores, and health comparisons based on their exclusive database.
  • “It also enables the veterinarian to remotely assess the pet’s condition using objective and accurate in its natural setting.”

CallTek Engages TRKD to Extend Healthcare Technology Support to Medical Practices and Remote Patient Monitoring

Retrieved on: 
Thursday, February 22, 2024

CallTek, Inc., a leader in white-label technical support services, has engaged TRKD Wellness Technologies as a strategic partner to deliver comprehensive technology support solutions to the healthcare industry including independent medical practices and Remote Patient Monitoring (RPM) management services.

Key Points: 
  • CallTek, Inc., a leader in white-label technical support services, has engaged TRKD Wellness Technologies as a strategic partner to deliver comprehensive technology support solutions to the healthcare industry including independent medical practices and Remote Patient Monitoring (RPM) management services.
  • TRKD develops and delivers telehealth and wellness software solutions for independent medical practices.
  • The partnership aims to transform the independent medical practice sector with integrated, efficient, and reliable solutions that enhance patient care, operational efficiency, and practice success.
  • “CallTek and TKRD will enable independent medical practices, Remote Patient Monitoring (RPM), hospital at home, skilled nursing, independent living and home care providers to access a seamless suite of services that will help improve patient outcomes, reduce costs, and increase revenue,” said Tony Espinoza, CEO, CallTek.

FEMET Showcases Intelligent Medical Service Platform at HIMSS, Eyeing Expansion into European and American Markets

Retrieved on: 
Friday, March 8, 2024

Through participation in the event, the firm aims to expand the reach of its smart healthcare service platform from Asia to European and American markets.

Key Points: 
  • Through participation in the event, the firm aims to expand the reach of its smart healthcare service platform from Asia to European and American markets.
  • During HIMSS 2024, FEMET, in partnership with Metal Industries Research & Development Centre, exhibited its EMCP at the Taiwan Theme Pavilion.
  • Hospitals can enhance their medical services by subscribing to TravelSIMcare (including medical video conferencing, patient registration, and medical payment) through the Microsoft cloud platform.
  • Looking forward, the company aspires to extend the two intelligent medical services to Europe and the United States, with the aim of providing medical services that transcend borders and distances."

PreemptiveAI Emerges From Stealth With a Groundbreaking Biomedical Foundation Model For Health Prediction

Retrieved on: 
Wednesday, March 6, 2024

Based in Seattle, WA and backed by an initial $6.4M in funding, the company is unveiling a revolutionary foundation model aimed at transforming health prediction and monitoring.

Key Points: 
  • Based in Seattle, WA and backed by an initial $6.4M in funding, the company is unveiling a revolutionary foundation model aimed at transforming health prediction and monitoring.
  • This model leverages advanced signal processing to interpret biomedical signals from smartphones and wearable devices, offering unprecedented insights into human physiology.
  • As PreemptiveAI prepares for further commercial deployments in 2024, it continues to strengthen its model through partnerships across various healthcare sectors.
  • The company is poised to redefine health diagnosis and management, marking a new era in medical excellence and preemptive health care.

Dr. John Mulhall Joins FirmTech's Scientific Advisory Board to Promote Innovation in Men's Sexual Health

Retrieved on: 
Wednesday, March 6, 2024

BOZEMAN, Mont., March 6, 2024 /PRNewswire/ -- FirmTech, the revolutionary sexual technology wellness company, today announced that John P. Mulhall, MD, MSc, FECSM, FACS, FRCSI, has joined its Scientific Advisory Board. Dr. Mulhall brings decades of experience and leadership in men's sexual health care to FirmTech, and a personal commitment to drive innovation that will improve men's lives. He will partner with renowned colleagues to provide independent guidance, analysis of sextech data, and evaluation of FirmTech product offerings to ensure they are science-backed and effective for men and women who want to improve their sexual performance and health.

Key Points: 
  • A world-renowned leader in men's sexual health, Mulhall joins esteemed colleagues dedicated to providing science-backed research that advances the field of sexual wellness
    BOZEMAN, Mont., March 6, 2024 /PRNewswire/ -- FirmTech , the revolutionary sexual technology wellness company, today announced that John P. Mulhall, MD, MSc, FECSM, FACS, FRCSI, has joined its Scientific Advisory Board.
  • Dr. Mulhall brings decades of experience and leadership in men's sexual health care to FirmTech, and a personal commitment to drive innovation that will improve men's lives.
  • "Wearable technology is the wave of the future for sexual wellness, and I'm excited to join FirmTech's independent scientific advisory board to help drive science-backed innovation," said Dr. Mulhall.
  • Dr. Mulhall is the Director of the Male Sexual and Reproductive Medicine Program at Memorial Sloan Kettering Cancer Center in New York City.

$7.25+ Bn Healthcare Electronic Data Interchange Markets - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2023 and 2024-2028

Retrieved on: 
Tuesday, March 5, 2024

DUBLIN, March 5, 2024 /PRNewswire/ -- The "Healthcare Electronic Data Interchange Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 5, 2024 /PRNewswire/ -- The "Healthcare Electronic Data Interchange Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ResearchAndMarkets.com's offering.
  • According to the Maryland Healthcare Commission, electronic claim submissions are identified as the most prevalent electronic transaction within the healthcare sector.
  • The integration of blockchain into EDI systems will ensure the immutability and integrity of healthcare data, reducing the risk of data tampering and fraud.
  • Company Profiles: Detailed analysis of the major companies present in the Global Healthcare Electronic Data Interchange Market.

SENA Health Announces Partnership with Inspira Health to Support Hospital-Level Care in the Home

Retrieved on: 
Tuesday, March 5, 2024

PHILADELPHIA, March 5, 2024 /PRNewswire/ -- SENA Health announces its partnership with Inspira Health to support patients receiving Healing at Home clinical services. The home-based services deliver advanced-level care to eligible Inspira Health patients in the comfort of their own homes. The program combines expert care with advanced technology to offer a seamless, integrated service that maximizes health outcomes.

Key Points: 
  • PHILADELPHIA, March 5, 2024 /PRNewswire/ -- SENA Health announces its partnership with Inspira Health to support patients receiving Healing at Home clinical services.
  • The home-based services deliver advanced-level care to eligible Inspira Health patients in the comfort of their own homes.
  • "Inspira Health sets itself apart as a truly innovative and forward-thinking organization in the region," said Dr. Anthony Wehbe, Founder and CEO of SENA Health.
  • Inspira Health, in collaboration with SENA, has recently obtained the CMS Acute Hospital Care at Home Waiver.

ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices™ Cardiopulmonary Management (CPM) System

Retrieved on: 
Tuesday, March 5, 2024

WILMINGTON, Mass., March 5, 2024 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of the Sensinel™ Cardiopulmonary Management (CPM) System. The compact wearable device is a non-invasive, remote management system that captures cardiopulmonary measurements for chronic disease management such as heart failure. It is the first FDA clearance the company has received in its 59-year history.

Key Points: 
  • WILMINGTON, Mass., March 5, 2024 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI ) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of the Sensinel™ Cardiopulmonary Management (CPM) System.
  • The compact wearable device is a non-invasive, remote management system that captures cardiopulmonary measurements for chronic disease management such as heart failure.
  • "Since our founding, ADI has focused on accelerating breakthroughs that enrich lives through innovative products," said Patrick O'Doherty, Senior Vice President of Digital Healthcare at ADI.
  • The Sensinel CPM System is the next-generation solution for management of cardiopulmonary diseases like heart failure.

Muon Space Establishes Communications, Confirms Health of Weather Satellite

Retrieved on: 
Tuesday, March 5, 2024

MOUNTAIN VIEW, Calif., March 5, 2024 /PRNewswire/ -- Muon Space, an end-to-end Space Systems Provider revolutionizing the way Earth is monitored from space, proudly announces the successful deployment and operational status of its second ESPA-class satellite, MuSat2. Launched aboard SpaceX's Transporter-10 mission from Vandenberg Space Force Base in California on March 4, MuSat2 is equipped with advanced software-defined radio frequency instrumentation to gather new insights for DoD weather programs.

Key Points: 
  • MOUNTAIN VIEW, Calif., March 5, 2024 /PRNewswire/ -- Muon Space , an end-to-end Space Systems Provider revolutionizing the way Earth is monitored from space, proudly announces the successful deployment and operational status of its second ESPA-class satellite, MuSat2.
  • "Muon Space's investment in cutting-edge, software-defined technologies, as demonstrated in MuSat2's RF payload, underscores our commitment to enabling rapid deployment of new space sensing capabilities for our customers," said Pascal Stang, CTO of Muon Space.
  • "Muon Space is leading a revolution in applying the power of LEO satellite constellations to the most urgent problems facing the planet."
  • AFLCMC's Weather Systems Branch then awarded Muon Space an option to their contract in July 2023.

Early Diagnosis & Remote Monitoring Fuel 8.2% CAGR in Wearable Medical Device Market, Reaching US$84.8 Billion by 2034 | Future Market Insights, Inc.

Retrieved on: 
Monday, March 4, 2024

NEWARK, Del., March 4, 2024 /PRNewswire/ -- The wearable medical device market is poised for significant growth, with a projected CAGR of 8.20% from 2024 to 2034. This translates to an expected market value increase from US$ 38,580.9 million in 2024 to a staggering US$ 84,848.6 million by 2034. 

Key Points: 
  • The global wearable medical device market, driven by the increasing demand for early disease detection and remote patient monitoring.
  • NEWARK, Del., March 4, 2024 /PRNewswire/ -- The wearable medical device market is poised for significant growth, with a projected CAGR of 8.20% from 2024 to 2034.
  • The wearable medical device market in France is projected to register a CAGR of 8% from 2024 to 2034.
  • The wearable medical device market in India is estimated to record a staggering CAGR of 18.40% over the forecast period.